Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alexion pharmaceuticals
biotech
boehringer ingelheim
boston
boston blog main
boston top stories
clinical trials
deals
hepatitis b
life sciences
national blog main
national top stories
rna interference
alnylam pharmaceutials
alnylam pharmaceuticals
arrowhead pharmaceuticals
dicerna pharamceuticals
dicerna pharmaceuticals
eli lilly
fda
hepatitis b virus
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
johnson & johnson
neurodegenerative diseases
patisiran
primary hyperoxaluria
roche
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
world health organization
What
dicerna
2
×
medicines
pharma
abandoning
ago
baggage
caught
causing
companies
cuts
deal
development
disease
drug
eye
free
gene
gets
hepatitis
intended
interference
long
pay
pharmaceuticals
producing
protein
research
rna
rnai
roche
signs
small
stop
team
wasn’t
Language
unset
Current search:
dicerna
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
